Trial Profile
A phase 1 safety, tolerability and pharmacokinetics of TAK-063 in healthy Japanese and non-Japanese volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Balipodect (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- 15 Dec 2017 New trial record